| Literature DB >> 33322125 |
Josefine Graef1, Carolin Senger2, Christoph Wetz1, Alexander D J Baur1,3, Anne K Kluge2, Mathias Lukas4,5, Julian M M Rogasch1, Thula C Walter-Rittel1, David Kohnert1, Marcus Makowski5,6, Güliz Acker7,8, Kai Huang1, Volker Budach2, Holger Amthauer1, Imke Schatka1, Christian Furth1.
Abstract
Ga-68-DOTATOC-PET/MRI can affect the planning target volume (PTV) definition of meningiomas before radiosurgery. A shorter tracer uptake time before image acquisition could allow the examination of more patients. The aim of this study was to investigate if shortening uptake time is possible without compromising diagnostic accuracy and PET volume. Fifteen patients (f = 12; mean age 52 years (34-80 years)) with meningiomas were prospectively examined with dynamic [68Ga]Ga-68-labeled [DOTA0-Phe1-Tyr3] octreotide (Ga-68-DOTATOC)-PET/MRI over 70 min before radiosurgery planning. Meningiomas were delineated manually in the PET dataset. PET volumes at each time point were compared to the reference standard 60 min post tracer injection (p.i.) using the Friedman test followed by a Wilcoxon signed-rank test and Bonferroni correction. In all patients, the earliest time point with 100% lesion detection compared to 60 min p.i. was identified. PET volumes did not change significantly from 15 min p.i. (p = 1.0) compared to 60 min p.i. The earliest time point with 100% lesion detection in all patients was 10 min p.i. In patients with meningiomas undergoing Ga-68-DOTATOC-PET, the tracer uptake time can safely be reduced to 15 min p.i. with comparable PET volume and 100% lesion detection compared to 60 min p.i.Entities:
Keywords: DOTATOC; PET; meningioma; radiosurgery
Year: 2020 PMID: 33322125 PMCID: PMC7763245 DOI: 10.3390/diagnostics10121084
Source DB: PubMed Journal: Diagnostics (Basel) ISSN: 2075-4418